Clinical Trial Update: A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 [Phase 2]

View source ↗

Summary

PepGen’s Phase 2 clinical study of PGN-EDODM1 for myotonic dystrophy type 1 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• PGN-EDODM1

Snippet

Sponsor: PepGen Inc | Conditions: Myotonic Dystrophy 1 | Phase 2 | Status: RECRUITING